Clinical Trial Update: Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining telmisartan as an adjunctive treatment for metabolic problems in schizophrenia or schizoaffective disorder; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-06-19